Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

**Background:** Allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be a lifesaving treatment for hematologic malignancies, but acute graft-versus-host-disease (aGVHD) is a potentially deadly adverse effect experienced by up to half of allo-HSCT recipients. Inadequate response to ster...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriel Tremblay, Dimitrios Tomaras, Eric Strati, Anna Forsythe
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2021-02-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/jheor.2021.19008
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items